Secukinumab is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, and psoriasis.
It targets member A from the cytokine family of interleukin 17.
Categories
Standard of CareStandard of CareSecukinumab is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, and psoriasis.
It targets member A from the cytokine family of interleukin 17.